Eyeworld Daily News

26 | EYEWORLD DAILY NEWS | MAY 16, 2020 DAILY NEWS ASCRS VIRTUAL ANNUAL MEETING noted the longer follow-up with the ICL V4c group, as well as a larger dataset in that group, but the data showed secondary surgical interven- tions in eight IPCL eyes (four were first rerotations) and five in ICL V4c eyes (two were first rerotations). "In conclusion, we found equally good visual and refrac- tive outcomes with the IPCL and ICL for the correction of high and moderate myopia with and without astigmatism," Dr. Taneri said, adding that there is no need for nomogram adjustment when transitioning from the ICL to IPCL. Longer follow-up is needed for the IPCL group. See SPS-104 for more in- formation. Editors' note: Dr. Taneri has financial interests with Polytech Domilens. Dr. Packer has no financial interests related to his presentation. A study presented by Suphi Taneri, MD, Bochum, Ger- many, compared two phakic posterior chamber IOLs. The study evaluated outcomes from the IPCL (Care Group India), which is not FDA approved, compared to the ICL V4c (STAAR Surgical). Astigmatic and non-astigmatic corrections were evaluated. The study included 114 ICL V4c implantations (64 toric) from 2012–2018 and 74 IPCL implantations (40 toric) from 2018–2019. The eyes had no prior history of ocular pathol- ogy and at least 3 months of follow-up. Visual acuity, spherical equivalent, and astig- matism at 3 months showed no significant difference between the two groups. Endothelial cell loss was not significant in either group, but Dr. Taneri noted the longer follow-up in the ICL V4c group. When spec- ifying adverse events, he again the small number of eyes with follow-up in that time period. Over the 11-year time- frame, the overall rate of adverse events was 1.2% with cataract formation, glaucoma, retinal detachment, and trau- matic incision opening being among them. Low vaults were typically the cause of the 4.5% of ICLs that were removed or replaced. Limitations to the study included those inherent with retrospective research and patient follow-up loss. In conclusion, Dr. Packer said, refractive results of ICLs were robust and stable over long-term follow-up, and vault sizes decreased over time, which suggests increased risk of cataract formation after 7 years. He also said the clini- cal significance of the mean endothelial cell loss of 14.4% at 5 years postop should be assessed. by Liz Hillman Editorial Co-Director A paper session on refractive procedure outcomes included a presentation from Kyle Packer, MD, Fort Gordon, Geor- gia, who discussed an 11-year retrospective chart review of surgical outcomes of posterior chamber IOLs in a U.S. military population. The study included 3,004 eyes that had an ICL implanted at a single treatment facility between 2008–2019. Most had statistically significant data out to 8 years of follow-up. ICLs represented about 5% of re- fractive cases at this center, Dr. Packer said. Data revealed that ICLs were often implanted due to abnormal corneal topogra- phy or high myopia. Postoperative refractive characteristics, Dr. Packer said, "reflect the young, active duty population and demonstrate the practice patterns of us- ing ICLs in moderate to high myopes with low astigmatism." Median spherical equivalents trend slightly more myopic over 7 years. He also said median uncorrected visual acuity was better than 20/25 and best-corrected was better than 20/20 at all time points out to postop year 7. He said postop data between 8 and 11 years is only descriptive due to Papers evaluate posterior chamber IOLs 2) When IOLs rotate, those located diagonally do so at a higher magnitude than those vertically or horizontally. 3) When IOLs rotate, those ini- tially placed against the rule, or horizontally, have a much stronger preference to rotate counterclockwise, compared to those initially placed verti- cally or diagonally. 4) When looking at the direc- tion of rotation in AcrySof lenses, those placed against the rule preferred to rotate counterclockwise. Those placed with the rule pre- ferred to rotate clockwise, and those placed diagonally didn't seem to favor one direction of rotation over another. The most important finding in this study, Dr. Kramer said, is the superiority of rotational stability of the AcrySof toric. View Dr. Kramer's presen- tation and others in the paper session SPS-102. Editors' note: Dr. Berdahl has finan- cial interests with Alcon, Johnson & Johnson Vision, and Bausch + Lomb. Dr. Hardten has financial interests with Johnson & Johnson Vision, ESI, and TLC Vision. Dr. Kramer has no financial interests related to his presentation. continued from page 24 "In conclusion, we found equally good visual and refractive outcomes with the IPCL and ICL for the correction of high and moderate myopia with and without astigmatism." —Suphi Taneri, MD

• Cover